Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Uncollected Medical Fees - Why Don't Patients Pay?
August 29, 2005
- REGULATORY NEWS IN BRIEF
August 29, 2005
- Nippon Chemiphar Announces New 3-Year Management Plan
August 22, 2005
- More than 400 Medical Institutions Issue GE Name Prescriptions
August 22, 2005
- MediciNova Starts PII Trial of Ibudilast for MS
August 22, 2005
- Burgeoning Clinical Trial Business in China
August 22, 2005
- 1st Qtr Business Results
August 22, 2005
- NEW PRODUCTS
August 22, 2005
- Associations Petition for Rapid Increase in Review Staff
August 22, 2005
- Olympus, Terumo to Develop New Medical Devices Based on Capital Alliance
August 22, 2005
- SELF-MEDICATION
August 22, 2005
- Retirees Drove Growth in Medical Expenditure in FY2004: Survey
August 22, 2005
- Council Calls for More Screening of Hepatitis C
August 22, 2005
- Record Number of High-cost Medical Bills in FY2004: Kenporen
August 22, 2005
- REGULATORY NEWS IN BRIEF
August 22, 2005
- Piecework System Encourages Unnecessary Healthcare: White Paper
August 22, 2005
- Sales of Olmetec Rising Steadily Since May: Sankyo
August 22, 2005
- AJHA Calls For Increases in Medical Fees
August 22, 2005
- MPC Takes 1st Step to Become Global Drug Discovery Company with Argatroban in Germany: Mr Komine
August 22, 2005
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
August 22, 2005
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…